BIDN39 — ISHARES GENOMICS IMMUNOLOGY AND HEALTHCARE ETF

ETF BDR: the receipt represents shares of a fund listed abroad, not of a company.

ETF BDRtype

Renda Variávelcategory (B3)

2022listed since

BRBIDNBDR007ISIN

50521CVM code

R$ 84.48close of 2026-06-26 · B3 (COTAHIST), updated nightly — the price the API, the MCP and the dump serve

1m +11.0% · 12m +56.7% · YTD +41.6% · 52-week R$ 59.64–84.48

15-minute delayed quote, shown by TradingView — display only: it never enters our API, MCP or dump

R$ 0.00 m/dayavg daily traded
last 60 sessions it traded

R$ 0.5091distributions, 12 months
2 payments · +0.60% of the pricesum per BDR, in reais, as B3 publishes it

+57.8%12-month return
with distributionsprice change plus distributions reinvested on the ex-date

What this page does not have: the ticker of the share abroad and how many shares each BDR represents. Both exist only in each program's prospectus, one PDF per depositary bank, with no structured list — so we do not guess them, and we do not compare the BDR price with the price abroad.

Price

Close, daily, 5 years · return +27.3% (+7.2% a year) · not split-adjustedR$ 84.48 2026-06-26

2023low R$ 43.44 · high R$ 84.482026

Closing price as traded on B3, in reais, not adjusted.

Return by window

	1 month	3 months	1 year	2 years	5 years	10 years
With distributions	+11.3%	+9.9%	+57.8%	+42.7%	—	—
Price only	+11.0%	+9.6%	+56.7%	+41.8%	—	—
Real (net of IPCA)	—	—	—	—	—	—

In reais: the BDR return already includes the exchange rate move, because the price is in reais.

Distributions

last day with right	type	per BDR	payment
2026-06-12	dividendo	R$ 0.217945	2026-06-24
2025-12-15	dividendo	R$ 0.291148	2025-12-29

Value per BDR in reais, as B3 publishes it in the company supplement.

Take this into your code

JSON from the same URL: GET /bdrs/BIDN39 with Accept: application/json and the X-API-Key header (AAPL34 answers without a key). Daily series at GET /bdrs/BIDN39/precos. Free key, no card.

Coverage: 43 sessions, 2023-01-12 → 2026-06-26 · sources: B3 (COTAHIST, BDR list and company supplement) · Descriptive, not a recommendation.

Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.

Numbers on this page are live. Data version 2026-10-01-cfo-metodo-direto · page generated 2026-10-12 23:04 UTC. If this does not match /saude, you are reading a cached copy.